BCR and myeloproliferative disorder: However, if BCR-ABL1 fusion occurred after a long period of Ph− MPN phase, such a clone might harbor other genetic aberrations, due to selective pressure from other drug treatments, for example, hydroxyurea, leading to an unfavorable treatment response.